Aimee J. Lenar

Insider

First SEC filing: Feb. 27, 2026 · Latest: Feb. 27, 2026

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 8 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
July 17, 2026	BHC	F	5,260	$4.83	$25,406	371,680 Direct	-1.40%	Disposed	41.7% (price as of 2026-08-20)
July 15, 2026	BHC	F	23,395	$4.89	$114,402	376,940 Direct	-5.84%	Disposed	40.0% (price as of 2026-08-20)
Feb. 26, 2026	BHC	F	17,578	$6.04	$106,171	400,335 Direct	-4.21%	Disposed	13.3% (price as of 2026-08-20)
Feb. 25, 2026	BHC	A	157,139	—	—	417,913 Direct	+60.26%	Acquired	(price as of 2026-08-20)
July 17, 2025	BHC	A	30,847	—	—	260,774 Direct	+13.42%	Acquired	(price as of 2026-08-20)
July 15, 2025	BHC	F	22,736	$6.42	$145,965	229,927 Direct	-9.00%	Disposed	6.6% (price as of 2026-08-20)
Feb. 26, 2025	BHC	A	108,311	—	—	252,663 Direct	+75.03%	Acquired	(price as of 2026-08-20)
July 15, 2024	BHC	A	144,352	—	—	144,352 Direct	—	Acquired	(price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Matched by name from proxy statements (DEF 14A) — verify against the filing.

President, US Pharma

Fiscal year	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension change	Other	Total
2025	$650,000	—	$1,958,861	—	$628,880	—	$26,750	$3,264,491

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.